Our finding that altered levels of tumor MCFA are associated with changes in tumor cell proliferation, tumor metastasis, and intracellular signal transduction pathway activation of Src and Akt highlights the importance of studying those molecules that influence FASN activity as potential targets for the treatment of breast cancer. This evidence concerns the gene SRC and breast carcinoma.